Live Breaking News & Updates on After First Dose

Nalfurafine capsules 2.5 μg, oral dispersing tablets 2.5 μg) in 1,186 patients with chronic liver disease and intractable pruritus. ....

Nalfurafine Remitch , Toray Industries Inc , Japanese Ministry Of Health , Administration Child , Japanese Pharmaceutical Affairs Law , Research Laboratories Of Toray Industries Inc , Drug Use , Pharmaceutical Research Laboratories , Toray Industries , Visual Analog Scale , Specific Drug Use Survey , Japanese Ministry , Good Post Marketing Study Practice , Conducting Post Marketing Surveillance , Japanese Pharmaceutical Affairs , Drug Dependence , Adverse Drug Reactions , Japanese Law , Medical Devices Law , Adverse Drug , Patient Characteristics , General Assessment , Ditch Improvement , Baseline Patient , Hepatic Cancer , Daily Dose ,